FCMR Human

Fc Fragment Of IgM Receptor Human Recombinant
Shipped with Ice Packs
In Stock

Description

Introduction to FCMR Human

FCMR (Fc fragment of IgM receptor), also known as FAIM3 or TOSO, is a type I transmembrane sialoglycoprotein primarily expressed on B cells, T cells, and natural killer (NK) cells. Its extracellular domain shares structural homology with immunoglobulin variable regions, enabling specific binding to the Fc region of IgM antibodies . FCMR plays critical roles in immune regulation, B cell homeostasis, and anti-tumor responses, with dysregulation linked to autoimmune diseases and malignancies like chronic lymphocytic leukemia (CLL) .

Biological Functions

FCMR regulates key immune processes:

B Cell Development and Homeostasis

  • Promotes B cell differentiation: FCMR-deficient mice exhibit reduced follicular (FO) B cells and increased peritoneal B-1a cells, suggesting a role in balancing B cell subsets .

  • Prevents autoimmunity: FCMR inhibits autoreactive B cells, as Fcmr−/− mice develop elevated autoantibodies, particularly in the peritoneum .

  • Modulates BCR signaling: Enhances tonic BCR signaling, supporting survival of marginal zone (MZ) and B-1a cells .

Immune Regulation

  • IgM-mediated responses: Binds pentameric and membrane-bound IgM, facilitating immune surveillance and pathogen clearance .

  • Anti-tumor immunity: Inhibits tumor-associated myeloid cell infiltration, as Fcmr−/− mice show increased neutrophils and monocytic dendritic cells in tumors .

Disease Associations

ConditionFCMR RoleSource
Chronic Lymphocytic Leukemia (CLL)Overexpressed on malignant B cells, correlating with disease progression .
AutoimmunityDeficiency increases autoantibodies and autoreactive B cells .

Comparative Analysis: Human vs. Mouse FCMR

FeatureHuman FCMRMouse FCMR
Binding SpecificityConstitutive IgM bindingTransient IgM binding during cell growth .
Tissue ExpressionLymphocytes, CLL cellsB cells, T cells, NK cells .
Structural Identity58% with mouse FCMRLarger cytoplasmic tail (422 vs. 390 aa) .

Therapeutic and Diagnostic Relevance

  • Target in CLL: Elevated FCMR expression on CLL B cells suggests potential for therapeutic targeting .

  • Biomarker: Soluble FCMR levels may correlate with disease severity in CLL patients .

Experimental Tools and Applications

ToolDescriptionApplication
Recombinant FCMR ProteinHis-tagged, non-glycosylated (27.2 kDa), expressed in E. coli .Binding assays, structural studies.
Monoclonal AntibodiesHM7 (blocks IgM binding), APC-conjugated for flow cytometry .Detection of FCMR on lymphocytes.

Product Specs

Introduction

Fas apoptotic inhibitory molecule 3 (FCMR) plays a role in immune system processes. FCMR protects cells from apoptosis induced by the proteins FADD, FAS, and TNF alpha, without overexpressing apoptosis inhibitors like BCLXL or BCL2. Instead of blocking apoptotic signals downstream, FCMR activates an inhibitory pathway that prevents CASP8 activation.

Description

Recombinant human FCMR, produced in E. coli, is a single, non-glycosylated polypeptide chain consisting of 243 amino acids (a.a 18-250), including a 10 a.a N-terminal His tag. The calculated molecular mass is 27.2 kDa.

Physical Appearance
Lyophilized powder, white in color, and filtered.
Formulation

FCMR is filtered (0.4 µm) and lyophilized from a solution of 50 mM acetate buffer, pH 4, at a concentration of 0.5 mg/ml.

Solubility

To prepare a working stock solution of approximately 0.5 mg/ml, add 0.1 M acetate buffer (pH 4) to the lyophilized pellet and allow it to dissolve completely. Please note that the solubility of this antigen is limited at higher concentrations.

Stability
Store the lyophilized protein at -20°C. After reconstitution, aliquot the product to minimize repeated freezing and thawing cycles. The reconstituted protein remains stable at 4°C for a limited time and shows no significant change after two weeks at this temperature.
Purity

Purity is determined to be greater than 95.0% by SDS-PAGE analysis.

Synonyms

Fas apoptotic inhibitory molecule 3, IgM Fc fragment receptor, Regulator of Fas-induced apoptosis Toso, FAIM3, TOSO.

Source
Escherichia Coli.
Amino Acid Sequence

MKHHHHHHAS RILPEVKVEG ELGGSVTIKC PLPEMHVRIY LCREMAGSGT CGTVVSTTNF IKAEYKGRVT LKQYPRKNLF LVEVTQLTES DSGVYACGAG MNTDRGKTQK VTLNVHSEYE PSWEEQPMPE TPKWFHLPYL FQMPAYASSS KFVTRVTTPA QRGKVPPVHH SSPTTQITHR PRVSRASSVA GDKPRTFLPS TTASKISALE GLLKPQTPSY NHHTRLHRQR ALDYGSQSGR EGQ.

Q&A

What is FCMR and what distinguishes it from other Fc receptors?

FCMR (Fc receptor for IgM, also known as FcμR) is a unique receptor that specifically binds to IgM antibodies. Unlike other Fc receptors that primarily associate with myeloid cells, FCMR is preferentially expressed by cells of the adaptive immune system and represents the only constitutively expressed Fc receptor on human T cells .

This selectivity suggests specialized functional roles for FCMR in IgM-mediated immune responses, though efforts to fully characterize these functions have been complicated by species-specific expression patterns between humans and mice.

Which cell populations express FCMR in humans?

The expression pattern of FCMR in humans differs significantly from that in mice, contributing to challenges in deciphering its normal physiological functions. In humans, FCMR expression occurs across multiple lymphocyte populations:

  • B cells

  • NK cells

  • T cells

Notably, FCMR stands as the only constitutively expressed Fc receptor on human T cells, suggesting a potentially important role in T cell biology . This broad distribution across adaptive immune cell populations contrasts with mice, where FCMR expression is primarily restricted to B cells .

What is the structural basis for FCMR recognition of IgM?

Recent cryo-electron microscopy (cryo-EM) studies have revealed detailed insights into how FCMR interacts with IgM. The binding interface involves three complementarity-determining region (CDR) loops in the FCMR Ig-like domain that interact specifically with the Cμ4 domains of IgM .

Key structural elements of this interaction include:

  • CDR loops: CDR1 (purple), CDR2 (green), and CDR3 (blue) loops of FCMR form specific contacts with two adjacent Cμ4 domains within an IgM subunit

  • Hydrogen bonding network: Multiple hydrogen bonds stabilize the FCMR-IgM interface, some of which are conserved with pIgR-D1/IgM interactions while others are unique to FCMR

  • Extended interactions: The CDR3 loop of FCMR makes additional contacts with neighboring Cμ4 domains and the tailpiece of IgM in certain binding configurations

Methodologically, these structural insights were obtained using cryo-EM analysis of the FcμR/IgM-Fc complex with resolutions ranging from 3.2-5.4 Å, enabling detailed visualization of the binding interface and identification of key interacting residues .

How many binding sites exist for FCMR on the IgM pentamer?

Structural analysis has identified eight binding sites for the human FCMR Ig domain on the IgM pentamer, distributed across both the front and back faces of the molecule . This arrangement includes:

FaceBinding SitesSubunitsNotes
Front4Fcμ1-Fcμ4Front of Fcμ5 blocked by J chain hairpin-1 loop
Back4Fcμ2-Fcμ5Back of Fcμ1 blocked by J chain hairpin-2 loop

The presence of the J chain appears to block potential binding sites at the front of Fcμ5 and the back of Fcμ1, reducing the theoretical maximum of ten binding sites to eight . Importantly, one of these eight binding sites overlaps with receptor binding sites for other molecules, suggesting potential competitive binding mechanisms that may regulate FCMR function .

Only the Ig-like domain of FCMR appears ordered in the structural analysis, indicating flexibility of the stalk region mediating membrane attachment. This flexibility likely facilitates dynamic interactions in the cellular context .

What factors affect FCMR expression on human lymphocytes?

Contrary to previous assumptions, recent research has uncovered that cell density rather than IgM abundance is the primary factor affecting FCMR display on human lymphocytes . Earlier studies had suggested that ligand-induced internalization by serum IgM contributed to low baseline FCMR expression, leading to recommendations for preincubation in IgM-free culture medium when studying FCMR.

  • Cell-surface FCMR expression was surprisingly unaffected by IgM abundance

  • FCMR was significantly downregulated in high-cell density cultures through an as-yet undefined mechanism

  • Ex vivo processing of whole blood decreased surface FCMR detection

These findings challenge previous methodological approaches and suggest that FCMR expression is likely greater on circulating lymphocytes than previously appreciated. Researchers should therefore consider cell density as a critical variable when designing experiments to study FCMR expression and function.

How do sample processing methods impact FCMR detection?

Sample processing methodologies significantly impact the measurement of FCMR expression, with important implications for experimental design and data interpretation . Researchers should consider the following methodological factors:

Processing FactorImpact on FCMRRecommendation
Whole blood ex vivo processingDecreases surface FCMR detectionMinimize processing time; consider direct whole blood analysis
Cell isolation proceduresHigh-density preparations reduce FCMR expressionControl and document cell densities; avoid overcrowding
Time between collection and analysisLonger intervals may alter expression profilesProcess samples promptly; establish consistent protocols
Culture conditionsCell proliferation can affect density and FCMR levelsMaintain standardized cell concentrations across experiments

These findings prompt new predictions about when and where FCMR might be available for functional interactions in vivo, suggesting that previous studies may have underestimated the physiological expression levels and potential functional significance of this receptor .

How can researchers optimally investigate FCMR-IgM binding specificity?

To effectively investigate the specificity of FCMR for IgM over other antibody isotypes, researchers should employ multiple complementary methodological approaches:

  • Structural analysis techniques:

    • Cryo-electron microscopy to visualize FCMR-IgM complexes at high resolution

    • X-ray crystallography of isolated domains to capture specific interaction details

    • Hydrogen-deuterium exchange mass spectrometry to map binding interfaces dynamically

  • Mutagenesis approaches:

    • Site-directed mutagenesis of key residues in the CDR loops of FCMR identified from structural studies

    • Creation of chimeric receptors exchanging domains between FCMR and pIgR to identify specificity-determining regions

    • CRISPR-Cas9 gene editing to introduce precise mutations in endogenous FCMR

  • Binding assays:

    • Surface plasmon resonance to quantify binding kinetics and affinity constants

    • Bio-layer interferometry with immobilized IgM versus other antibody isotypes

    • Cell-based binding assays using flow cytometry with fluorescently labeled antibodies

These methodologies should be applied systematically to build a comprehensive understanding of the molecular basis for FCMR's IgM specificity, potentially leading to therapeutic applications targeting this receptor .

What are the functional implications of multiple FCMR binding sites on IgM?

The presence of eight binding sites for FCMR on the IgM pentamer has significant functional implications that researchers can investigate through several methodological approaches:

  • Avidity effects:

    • The multivalent binding arrangement likely enables high-avidity interactions despite potentially moderate affinity of individual binding events

    • This may explain FCMR's effectiveness in capturing IgM at physiological concentrations

  • Signaling complexity:

    • Multiple binding sites could enable complex signaling patterns when FCMR engages with IgM

    • Partial occupancy versus full occupancy might trigger different downstream pathways

  • Competitive binding mechanisms:

    • One binding site overlaps with sites for other receptors, suggesting competitive regulation

    • The J chain blocks two potential binding sites, potentially regulating the maximum number of FCMR molecules that can simultaneously bind

Methodologically, researchers can investigate these functional implications through:

  • Single-molecule imaging techniques to visualize sequential binding events

  • Engineered IgM variants with selective binding site mutations

  • Quantitative signaling assays comparing responses to IgM with different binding site availability

These approaches would help elucidate how the structural arrangement of multiple binding sites contributes to FCMR's biological functions in different immunological contexts .

What approaches should researchers use to accurately measure FCMR expression?

For accurate measurement of FCMR expression on human lymphocytes, researchers should implement the following methodological strategies:

  • Fresh sample analysis:

    • When possible, analyze FCMR expression directly from fresh whole blood samples

    • If using isolated cells, minimize processing time and maintain appropriate cell separation

    • Document all processing steps and timing for reproducibility

  • Cell density control:

    • Standardize and report cell densities in all experiments

    • Use low-density cultures when higher FCMR expression is required for detection

    • Include appropriate controls at multiple density points to calibrate measurements

  • Complementary detection methods:

    • Flow cytometry using validated anti-FCMR antibodies

    • RT-qPCR for FCMR mRNA quantification to complement protein expression data

    • Immunofluorescence microscopy to assess spatial distribution on cell surfaces

  • Comparative baseline establishment:

    • Include timepoint zero measurements immediately after collection

    • Compare expression levels between whole blood, freshly isolated cells, and cultured cells

    • Document changes during experimental manipulation to understand FCMR dynamics

These methodological considerations are essential for generating reliable and physiologically relevant data on FCMR expression, particularly given the emerging understanding that traditional approaches may underestimate actual expression levels .

How should cell density be managed in FCMR research protocols?

Given the significant impact of cell density on FCMR expression, researchers should implement specific protocols to manage this variable:

  • Standardized density controls:

    • Establish and document optimal cell density ranges for FCMR studies

    • Ensure consistent seeding densities across experimental replicates

    • Include density gradients as internal controls when appropriate

  • Culture system considerations:

    • Use culture vessels with consistent surface area-to-volume ratios

    • Implement gentle agitation systems to prevent localized high-density regions

    • Consider three-dimensional culture systems that better mimic physiological spacing

  • Temporal monitoring:

    • Track cell proliferation throughout experiments

    • Adjust seeding densities based on expected proliferation rates

    • Establish consistent timepoints for analysis relative to density changes

  • Physiological relevance:

    • Consider how experimental densities compare to those in various lymphoid tissues

    • Investigate density-dependent regulation as a potential physiological mechanism

    • Design experiments that reflect relevant in vivo cellular environments

By carefully controlling cell density as an experimental variable, researchers can generate more consistent and physiologically relevant data on FCMR expression and function, leading to better understanding of its role in immune regulation .

Product Science Overview

Introduction

The Fc fragment of IgM receptor, also known as FcμR, is a crucial component of the immune system. It is the newest member of the Fc receptor family, having been identified in 2009 . This receptor is uniquely expressed by lymphocytes, which suggests it has distinct functions compared to other Fc receptors that are expressed by various immune and non-hematopoietic cells .

Structure and Function

The FcμR is a membrane-bound receptor that specifically binds to the Fc region of Immunoglobulin M (IgM) antibodies. IgM is the first antibody to emerge during phylogeny, ontogeny, and immune responses, serving as a first line of defense . The Fc region of IgM contains three heavy chain constant domains (Cμ2-Cμ4) in each polypeptide chain . The interaction between FcμR and the Fc region of IgM is critical for mediating various immune responses.

Physiological Roles

FcμR plays a significant role in regulating B cell tolerance. Studies involving FcμR-deficient mice have shown a propensity to produce autoantibodies of both IgM and IgG isotypes, indicating a regulatory function of FcμR in maintaining immune homeostasis . Additionally, FcμR is involved in protecting cells from apoptosis induced by proteins such as FADD, FAS, and TNF alpha, without overexpressing inhibitors of apoptosis like BCLXL or BCL2 .

Pathophysiological Roles

Elevated levels of a soluble FcμR isoform have been observed in serum samples from patients with chronic lymphocytic leukemia and antibody-mediated autoimmune disorders . This suggests that persistent B cell receptor stimulation can lead to increased levels of soluble FcμR, which may have implications in the pathogenesis of these diseases.

Therapeutic Potential

Understanding the role of FcμR in immune regulation opens up potential therapeutic avenues. Targeting FcμR could be a strategy for modulating immune responses in autoimmune diseases and certain types of leukemia. Further research is needed to fully elucidate the mechanisms by which FcμR functions and its potential as a therapeutic target.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.